| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02:26 | Talen Energy (TLN) is Down 23% This Year. But Mizuho Expects a Rebound | ||
| 02:26 | Centrus Energy (LEU) May Have Found its Next Major Growth Opportunity | ||
| 01:26 | Better Than Wall Street: These Stocks Just Exceeded Earnings Expectations | ||
| 01:26 | Enovix (ENVX) Plans to Double Drone Battery Capacity. Is a $183M Pipeline Enough to Justify the Expansion? | ||
| Di | Wolfspeed (WOLF) Says AI Data Center Revenue More Than Doubled. Can it Restore Positive Gross Margins? | ||
| Di | BILL (BILL) Expanded Non-GAAP Operating Profit While Reported Business Metric Fell. Has its Efficiency Push Gone Too Far? | ||
| Di | Daqo (DQ) Has $1.9B in Liquidity and a Negative Gross Margin. Which Number Matters More? | ||
| Di | ZIM (ZIM) Beat Estimates but Trades 19% Below its Buyout Price. Is the Deal Discount Too Wide? | ||
| Di | Redditors Are Skeptical of SpaceX's Orbital Data Centers. Are They Right? | ||
| Di | Home Depot (HD) Beat Q2 Estimates. What Did the $685M Tariff Refund Change? | ||
| Di | Michael Burry Says This $21 Billion AI Startup Could Crack Nvidia's Empire | ||
| Di | Baidu (BIDU) Sank 12.7% After Earnings. Is Its AI Transition Losing Momentum? | ||
| Di | Performance Food (PFGC) Grew Sales 6.4% as Product Inflation Hit 4.7%. How Much Growth Was Real? | ||
| Di | AEVEX (AVEX) Doubled Revenue, then Announced a $650M Acquisition. Is Growth Outrunning Dilution? | ||
| Di | Canadian Pacific Kansas City (CP) Reaffirms 36.9% Locomotive Emissions Reduction Goal by 2030 | ||
| Di | What Does the Pizza Hut Sale Mean for Yum! Brands (YUM)? | ||
| Di | QXO (QXO) is Rebuilding Business Models for Greater Value | ||
| Di | AI is Sharpening Ryan Specialty Holdings (RYAN), Not Replacing Them | ||
| Di | Newmont (NEM) Faces Gold Above $4,500. Will Rising Costs Dilute the Windfall? | ||
| Di | ZenaTech Completes Acquisition of ESM Software, Adding Strategy Execution and Compliance Software to its Enterprise SaaS Division, with Revenue from Government, Healthcare and Financial Services Customers | ||
| Di | Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success? | ||
| Di | AI and Insurance: Is Brown & Brown (BRO) Facing Extinction or Evolution? | ||
| Di | Lowe's (LOW) Cut Its Outlook. Is Pro Demand Strong Enough to Offset the DIY Slump? | ||
| Di | Affirm (AFRM) Slipped After Klarna Cut Guidance. Category Warning or Share-Gain Opportunity? | ||
| Di | Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda's Growth Runway? |